CD86 and B-cell chronic lymphocytic leukemia: In OSU-CLL cells treated with ACY738, expression of MHCI, MHCII, and CD86 were increased, while expression of PD-L1 and 41BB-L were consistently decreased compared to DMSO-treated cells (Figure 4A and Figure S4A).